US equities
|
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MU
$934.27
▼-4.98%
MSFT
$530.14
▼-0.16%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MU
$934.27
▼-4.98%
MSFT
$530.14
▼-0.16%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by BostonGene
< Previous
1
2
3
Next >
BostonGene Named a Fierce Life Sciences Innovation Awards Winner in the AI Innovation Category
March 13, 2025
From
BostonGene
Via
Business Wire
BostonGene Collaborates with BeiGene to Advance Biomarker Discovery in Mantle Cell Lymphoma
February 11, 2025
From
BostonGene
Via
Business Wire
BostonGene Contributes to Friends of Cancer Research White Paper Introducing a Novel Process for Companion Diagnostics for Rare Biomarkers and Indications
February 04, 2025
From
BostonGene
Via
Business Wire
BostonGene Evaluates Novel Therapies and Immune System Profiling as a Marker of Response in Patients with Gastrointestinal Cancers
January 14, 2025
From
BostonGene
Via
Business Wire
BostonGene Unveils Transformative Breast Cancer Research at 2024 San Antonio Breast Cancer Symposium, Showcasing Precision Tools for Tailored Treatment Approaches
December 10, 2024
From
BostonGene
Via
Business Wire
BostonGene Announces Twelve Abstracts Selected for Presentation at the 66th American Society of Hematology Annual Meeting & Exposition
December 06, 2024
From
BostonGene
Via
Business Wire
BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2024 Annual Meeting
November 21, 2024
From
BostonGene
Via
Business Wire
GlobalData Honors BostonGene with Five Awards in the 2024 Pharmaceutical Technology Excellence Awards
November 12, 2024
From
BostonGene
Via
Business Wire
BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s Annual Meeting
November 06, 2024
From
BostonGene
Via
Business Wire
BostonGene to Participate in Pathology Visions 2024, Driving Collaborative Advancements in Digital Pathology and Regulatory Science
November 01, 2024
From
BostonGene
Via
Business Wire
BostonGene to Showcase Innovative Precision Medicine Strategies for Non-Small Cell Lung Cancer at the Advancing Precision Medicine Conference 2024
October 31, 2024
From
BostonGene
Via
Business Wire
Fujita Health University and BostonGene Expand Access to Genomic Cancer Testing with Tumor Portrait™ at Haneda Clinic
October 22, 2024
From
BostonGene
Via
Business Wire
BostonGene and Sarah Cannon Research Institute Collaborate to Accelerate the Development of Targeted Cancer Therapies and Improve Patient Outcomes
October 15, 2024
From
BostonGene
Via
Business Wire
BostonGene Announces Partnership with Takeda to Evaluate Immunotherapies Using AI-Powered Molecular Profiling
August 01, 2024
From
BostonGene
Via
Business Wire
BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Collaborate to Advance Care for Cancer Patients
July 23, 2024
From
BostonGene
Via
Business Wire
BostonGene Highlights Its AI-Powered Multiomics Platform at hubXchange’s Immuno-Oncology Xchange Boston 2024
June 18, 2024
From
BostonGene
Via
Business Wire
BostonGene Announces Seven Abstract Acceptances at the 2024 American Society of Clinical Oncology Annual Meeting
May 29, 2024
From
BostonGene
Via
Business Wire
BostonGene and the Medical College of Wisconsin Announce the Publication and Journal Cover Feature in Gastroenterology Highlighting Transcriptomic-Based Tumor Microenvironment Classification for Precision Medicine in Pancreatic Cancer
May 06, 2024
From
BostonGene
Via
Business Wire
BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
April 30, 2024
From
BostonGene
Via
Business Wire
BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients
April 16, 2024
From
BostonGene
Via
Business Wire
BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2024
April 02, 2024
From
BostonGene
Via
Business Wire
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
March 19, 2024
From
BostonGene
Via
Business Wire
BostonGene Wins Four GlobalData’s Clinical Trials Arena Excellence Awards
March 12, 2024
From
BostonGene
Via
Business Wire
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell
March 07, 2024
From
BostonGene
Via
Business Wire
Frost & Sullivan Recognizes BostonGene with Frost & Sullivan’s Enabling Technology Leadership Award for Revolutionizing Precision Oncology Diagnostics
February 27, 2024
From
BostonGene
Via
Business Wire
BostonGene Bolsters Leadership Team to Accelerate Innovation and Growth
February 22, 2024
From
BostonGene
Via
Business Wire
BostonGene to Showcase Comprehensive Portfolio of Advanced Diagnostic Tools and Technologies at the 21st Japanese Society of Medical Oncology Annual Meeting
February 20, 2024
From
BostonGene
Via
Business Wire
BostonGene Demonstrates Benefits of Integrated Tumor Tissue and Blood Profiling at SLAS2024 International Conference and Exhibition
February 06, 2024
From
BostonGene
Via
Business Wire
BostonGene and Duke University Announce Master Collaboration Agreement
January 23, 2024
From
BostonGene
Via
Business Wire
GlobalData Names BostonGene Leading Innovator in AI-Driven Drug Repurposing
January 03, 2024
From
BostonGene
Via
Business Wire
< Previous
1
2
3
Next >
